Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: Prospective follow-up of 245 clinical high-risk outpatients in four countries
Abstract Background In selected samples, a considerable number of patients at clinical high risk of psychosis (CHR) are found to meet criteria for co-morbid clinical psychiatric disorders. It is not known how clinical diagnoses correspond to or even predict transitions to psychosis (TTP). Our aim wa...
Gespeichert in:
Veröffentlicht in: | Schizophrenia research 2012-07, Vol.138 (2), p.192-197 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 197 |
---|---|
container_issue | 2 |
container_start_page | 192 |
container_title | Schizophrenia research |
container_volume | 138 |
creator | Salokangas, Raimo K.R Ruhrmann, Stephan von Reventlow, Heinrich Graf Heinimaa, Markus Svirskis, Tanja From, Tiina Luutonen, Sinikka Juckel, Georg Linszen, Don Dingemans, Peter Birchwood, Max Patterson, Paul Schultze-Lutter, Frauke Klosterkötter, Joachim |
description | Abstract Background In selected samples, a considerable number of patients at clinical high risk of psychosis (CHR) are found to meet criteria for co-morbid clinical psychiatric disorders. It is not known how clinical diagnoses correspond to or even predict transitions to psychosis (TTP). Our aim was to examine distributions of life-time and current Axis I diagnoses, and their association with TTP in CHR patients. Methods In the EPOS (European Prediction of Psychosis Study) project, six European outpatient centres in four countries examined 245 young help-seeking patients, who fulfilled the inclusion criteria for clinical risk of psychosis according to the Structured Interview for Prodromal Syndromes (SIPS 3.0) or the Bonn Scale for the Assessment of Basic Symptoms — Prediction List basic symptoms (BASBS-P). Patients who had experienced a psychotic episode lasting more than one week were excluded. Baseline and life-time diagnoses were assessed by the Structured Clinical Interview for DSM-IV (SCID-I). TTP was defined by continuation of BLIPS for more than seven days and predicted in Cox-regression analysis. Results Altogether, 71% of the CHR patients had one or more life-time and 62% one or more current SCID-I diagnosis; about a half in each category received a diagnosis of life-time depressive and anxiety disorder. Currently, 34% suffered from depressive and 39% from anxiety disorder. Four percent received a current SCID diagnosis of bipolar, and 6.5% of somatoform disorder. During follow-up, 37 (15.1%) patients had developed full-blown psychosis. In bivariate analyses, current non-psychotic bipolar disorder associated significantly with TTP. In multivariate analyses, current bipolar disorder, somatoform and unipolar depressive disorders associated positively, and anxiety disorders negatively, with TTP. Conclusions Both life-time and current mood and anxiety disorders are highly prevalent among clinical help-seeking CHR patients and need to be carefully evaluated. Among CHR patients, occurrence of bipolar, somatoform and depressive disorders seems to predict TTP, while occurrence of anxiety disorder may predict non-transition to psychosis. |
doi_str_mv | 10.1016/j.schres.2012.03.008 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1031159496</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0920996412001612</els_id><sourcerecordid>1031159496</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-d9ce168117845ad2c1ae2937a6505432894363c0f9a6019922c825764a6ffbe63</originalsourceid><addsrcrecordid>eNqFks9u1DAQxi0EokvhDRDyBYlLgv_FiTkgVVWBSpVaqXC2XMfpOs3GwZMU9ol4TWa12yIhJE724TffzHzfEPKas5Izrt_3Jfh1DlAKxkXJZMlY84SseFXLQlTMPCUrZgQrjNHqiLwA6BljvGL1c3IkhNLKCLEiv05-RqDntI3udkwQgLqxpXN2I8Q5ppHOiU6w9esEyMWR-iGO0buBruPtusgR7ujk5hjGGejZ1eU1nXLqg58_0KucYMJfvA-0S8OQfhTLRFNHhar-JZOW-VEJG3VpydSnZZxzDPCSPOvcAOHV4T0m3z6dfT39Ulxcfj4_PbkovFL1XLTGB64bzutGVa4VnrsgjKydrlilpGiMklp61hmnGTdogW9EVWvldNfdBC2Pybu9Lq7xfQkw200EH4bBjSEtYDmTnFdGmR2q9qjHRSGHzk45blzeImR3Edne7iOyu4gskxYjwrI3hw7LzSa0j0UPmSDw9gA4QIc6zMJH-MPh4NpohtzHPRfQj_sYMnZD93xoY0bbbZvi_yb5W-AhlbuwDdBjACN6bbkFrLHXu3PaXRMXeEiaC_kb5xbHjw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1031159496</pqid></control><display><type>article</type><title>Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: Prospective follow-up of 245 clinical high-risk outpatients in four countries</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Salokangas, Raimo K.R ; Ruhrmann, Stephan ; von Reventlow, Heinrich Graf ; Heinimaa, Markus ; Svirskis, Tanja ; From, Tiina ; Luutonen, Sinikka ; Juckel, Georg ; Linszen, Don ; Dingemans, Peter ; Birchwood, Max ; Patterson, Paul ; Schultze-Lutter, Frauke ; Klosterkötter, Joachim</creator><creatorcontrib>Salokangas, Raimo K.R ; Ruhrmann, Stephan ; von Reventlow, Heinrich Graf ; Heinimaa, Markus ; Svirskis, Tanja ; From, Tiina ; Luutonen, Sinikka ; Juckel, Georg ; Linszen, Don ; Dingemans, Peter ; Birchwood, Max ; Patterson, Paul ; Schultze-Lutter, Frauke ; Klosterkötter, Joachim ; the EPOS group ; EPOS group</creatorcontrib><description>Abstract Background In selected samples, a considerable number of patients at clinical high risk of psychosis (CHR) are found to meet criteria for co-morbid clinical psychiatric disorders. It is not known how clinical diagnoses correspond to or even predict transitions to psychosis (TTP). Our aim was to examine distributions of life-time and current Axis I diagnoses, and their association with TTP in CHR patients. Methods In the EPOS (European Prediction of Psychosis Study) project, six European outpatient centres in four countries examined 245 young help-seeking patients, who fulfilled the inclusion criteria for clinical risk of psychosis according to the Structured Interview for Prodromal Syndromes (SIPS 3.0) or the Bonn Scale for the Assessment of Basic Symptoms — Prediction List basic symptoms (BASBS-P). Patients who had experienced a psychotic episode lasting more than one week were excluded. Baseline and life-time diagnoses were assessed by the Structured Clinical Interview for DSM-IV (SCID-I). TTP was defined by continuation of BLIPS for more than seven days and predicted in Cox-regression analysis. Results Altogether, 71% of the CHR patients had one or more life-time and 62% one or more current SCID-I diagnosis; about a half in each category received a diagnosis of life-time depressive and anxiety disorder. Currently, 34% suffered from depressive and 39% from anxiety disorder. Four percent received a current SCID diagnosis of bipolar, and 6.5% of somatoform disorder. During follow-up, 37 (15.1%) patients had developed full-blown psychosis. In bivariate analyses, current non-psychotic bipolar disorder associated significantly with TTP. In multivariate analyses, current bipolar disorder, somatoform and unipolar depressive disorders associated positively, and anxiety disorders negatively, with TTP. Conclusions Both life-time and current mood and anxiety disorders are highly prevalent among clinical help-seeking CHR patients and need to be carefully evaluated. Among CHR patients, occurrence of bipolar, somatoform and depressive disorders seems to predict TTP, while occurrence of anxiety disorder may predict non-transition to psychosis.</description><identifier>ISSN: 0920-9964</identifier><identifier>EISSN: 1573-2509</identifier><identifier>DOI: 10.1016/j.schres.2012.03.008</identifier><identifier>PMID: 22464922</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Adolescent ; Adult ; Adult and adolescent clinical studies ; Anxiety Disorders - epidemiology ; Axis I diagnoses ; Biological and medical sciences ; Bipolar Disorder - epidemiology ; Clinical high-risk patients ; Comorbidity ; Depressive Disorder - epidemiology ; Europe - epidemiology ; Female ; Follow-Up Studies ; Humans ; Male ; Medical sciences ; Other psychotic disorders ; Prospective Studies ; Psychiatry ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychoses ; Psychotic Disorders - epidemiology ; Risk Factors ; Somatoform Disorders - epidemiology ; Transition to psychosis</subject><ispartof>Schizophrenia research, 2012-07, Vol.138 (2), p.192-197</ispartof><rights>Elsevier B.V.</rights><rights>2012 Elsevier B.V.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-d9ce168117845ad2c1ae2937a6505432894363c0f9a6019922c825764a6ffbe63</citedby><cites>FETCH-LOGICAL-c447t-d9ce168117845ad2c1ae2937a6505432894363c0f9a6019922c825764a6ffbe63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0920996412001612$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26016960$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22464922$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salokangas, Raimo K.R</creatorcontrib><creatorcontrib>Ruhrmann, Stephan</creatorcontrib><creatorcontrib>von Reventlow, Heinrich Graf</creatorcontrib><creatorcontrib>Heinimaa, Markus</creatorcontrib><creatorcontrib>Svirskis, Tanja</creatorcontrib><creatorcontrib>From, Tiina</creatorcontrib><creatorcontrib>Luutonen, Sinikka</creatorcontrib><creatorcontrib>Juckel, Georg</creatorcontrib><creatorcontrib>Linszen, Don</creatorcontrib><creatorcontrib>Dingemans, Peter</creatorcontrib><creatorcontrib>Birchwood, Max</creatorcontrib><creatorcontrib>Patterson, Paul</creatorcontrib><creatorcontrib>Schultze-Lutter, Frauke</creatorcontrib><creatorcontrib>Klosterkötter, Joachim</creatorcontrib><creatorcontrib>the EPOS group</creatorcontrib><creatorcontrib>EPOS group</creatorcontrib><title>Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: Prospective follow-up of 245 clinical high-risk outpatients in four countries</title><title>Schizophrenia research</title><addtitle>Schizophr Res</addtitle><description>Abstract Background In selected samples, a considerable number of patients at clinical high risk of psychosis (CHR) are found to meet criteria for co-morbid clinical psychiatric disorders. It is not known how clinical diagnoses correspond to or even predict transitions to psychosis (TTP). Our aim was to examine distributions of life-time and current Axis I diagnoses, and their association with TTP in CHR patients. Methods In the EPOS (European Prediction of Psychosis Study) project, six European outpatient centres in four countries examined 245 young help-seeking patients, who fulfilled the inclusion criteria for clinical risk of psychosis according to the Structured Interview for Prodromal Syndromes (SIPS 3.0) or the Bonn Scale for the Assessment of Basic Symptoms — Prediction List basic symptoms (BASBS-P). Patients who had experienced a psychotic episode lasting more than one week were excluded. Baseline and life-time diagnoses were assessed by the Structured Clinical Interview for DSM-IV (SCID-I). TTP was defined by continuation of BLIPS for more than seven days and predicted in Cox-regression analysis. Results Altogether, 71% of the CHR patients had one or more life-time and 62% one or more current SCID-I diagnosis; about a half in each category received a diagnosis of life-time depressive and anxiety disorder. Currently, 34% suffered from depressive and 39% from anxiety disorder. Four percent received a current SCID diagnosis of bipolar, and 6.5% of somatoform disorder. During follow-up, 37 (15.1%) patients had developed full-blown psychosis. In bivariate analyses, current non-psychotic bipolar disorder associated significantly with TTP. In multivariate analyses, current bipolar disorder, somatoform and unipolar depressive disorders associated positively, and anxiety disorders negatively, with TTP. Conclusions Both life-time and current mood and anxiety disorders are highly prevalent among clinical help-seeking CHR patients and need to be carefully evaluated. Among CHR patients, occurrence of bipolar, somatoform and depressive disorders seems to predict TTP, while occurrence of anxiety disorder may predict non-transition to psychosis.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Adult and adolescent clinical studies</subject><subject>Anxiety Disorders - epidemiology</subject><subject>Axis I diagnoses</subject><subject>Biological and medical sciences</subject><subject>Bipolar Disorder - epidemiology</subject><subject>Clinical high-risk patients</subject><subject>Comorbidity</subject><subject>Depressive Disorder - epidemiology</subject><subject>Europe - epidemiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Other psychotic disorders</subject><subject>Prospective Studies</subject><subject>Psychiatry</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychoses</subject><subject>Psychotic Disorders - epidemiology</subject><subject>Risk Factors</subject><subject>Somatoform Disorders - epidemiology</subject><subject>Transition to psychosis</subject><issn>0920-9964</issn><issn>1573-2509</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFks9u1DAQxi0EokvhDRDyBYlLgv_FiTkgVVWBSpVaqXC2XMfpOs3GwZMU9ol4TWa12yIhJE724TffzHzfEPKas5Izrt_3Jfh1DlAKxkXJZMlY84SseFXLQlTMPCUrZgQrjNHqiLwA6BljvGL1c3IkhNLKCLEiv05-RqDntI3udkwQgLqxpXN2I8Q5ppHOiU6w9esEyMWR-iGO0buBruPtusgR7ujk5hjGGejZ1eU1nXLqg58_0KucYMJfvA-0S8OQfhTLRFNHhar-JZOW-VEJG3VpydSnZZxzDPCSPOvcAOHV4T0m3z6dfT39Ulxcfj4_PbkovFL1XLTGB64bzutGVa4VnrsgjKydrlilpGiMklp61hmnGTdogW9EVWvldNfdBC2Pybu9Lq7xfQkw200EH4bBjSEtYDmTnFdGmR2q9qjHRSGHzk45blzeImR3Edne7iOyu4gskxYjwrI3hw7LzSa0j0UPmSDw9gA4QIc6zMJH-MPh4NpohtzHPRfQj_sYMnZD93xoY0bbbZvi_yb5W-AhlbuwDdBjACN6bbkFrLHXu3PaXRMXeEiaC_kb5xbHjw</recordid><startdate>20120701</startdate><enddate>20120701</enddate><creator>Salokangas, Raimo K.R</creator><creator>Ruhrmann, Stephan</creator><creator>von Reventlow, Heinrich Graf</creator><creator>Heinimaa, Markus</creator><creator>Svirskis, Tanja</creator><creator>From, Tiina</creator><creator>Luutonen, Sinikka</creator><creator>Juckel, Georg</creator><creator>Linszen, Don</creator><creator>Dingemans, Peter</creator><creator>Birchwood, Max</creator><creator>Patterson, Paul</creator><creator>Schultze-Lutter, Frauke</creator><creator>Klosterkötter, Joachim</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120701</creationdate><title>Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: Prospective follow-up of 245 clinical high-risk outpatients in four countries</title><author>Salokangas, Raimo K.R ; Ruhrmann, Stephan ; von Reventlow, Heinrich Graf ; Heinimaa, Markus ; Svirskis, Tanja ; From, Tiina ; Luutonen, Sinikka ; Juckel, Georg ; Linszen, Don ; Dingemans, Peter ; Birchwood, Max ; Patterson, Paul ; Schultze-Lutter, Frauke ; Klosterkötter, Joachim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-d9ce168117845ad2c1ae2937a6505432894363c0f9a6019922c825764a6ffbe63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Adult and adolescent clinical studies</topic><topic>Anxiety Disorders - epidemiology</topic><topic>Axis I diagnoses</topic><topic>Biological and medical sciences</topic><topic>Bipolar Disorder - epidemiology</topic><topic>Clinical high-risk patients</topic><topic>Comorbidity</topic><topic>Depressive Disorder - epidemiology</topic><topic>Europe - epidemiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Other psychotic disorders</topic><topic>Prospective Studies</topic><topic>Psychiatry</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychoses</topic><topic>Psychotic Disorders - epidemiology</topic><topic>Risk Factors</topic><topic>Somatoform Disorders - epidemiology</topic><topic>Transition to psychosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salokangas, Raimo K.R</creatorcontrib><creatorcontrib>Ruhrmann, Stephan</creatorcontrib><creatorcontrib>von Reventlow, Heinrich Graf</creatorcontrib><creatorcontrib>Heinimaa, Markus</creatorcontrib><creatorcontrib>Svirskis, Tanja</creatorcontrib><creatorcontrib>From, Tiina</creatorcontrib><creatorcontrib>Luutonen, Sinikka</creatorcontrib><creatorcontrib>Juckel, Georg</creatorcontrib><creatorcontrib>Linszen, Don</creatorcontrib><creatorcontrib>Dingemans, Peter</creatorcontrib><creatorcontrib>Birchwood, Max</creatorcontrib><creatorcontrib>Patterson, Paul</creatorcontrib><creatorcontrib>Schultze-Lutter, Frauke</creatorcontrib><creatorcontrib>Klosterkötter, Joachim</creatorcontrib><creatorcontrib>the EPOS group</creatorcontrib><creatorcontrib>EPOS group</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Schizophrenia research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salokangas, Raimo K.R</au><au>Ruhrmann, Stephan</au><au>von Reventlow, Heinrich Graf</au><au>Heinimaa, Markus</au><au>Svirskis, Tanja</au><au>From, Tiina</au><au>Luutonen, Sinikka</au><au>Juckel, Georg</au><au>Linszen, Don</au><au>Dingemans, Peter</au><au>Birchwood, Max</au><au>Patterson, Paul</au><au>Schultze-Lutter, Frauke</au><au>Klosterkötter, Joachim</au><aucorp>the EPOS group</aucorp><aucorp>EPOS group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: Prospective follow-up of 245 clinical high-risk outpatients in four countries</atitle><jtitle>Schizophrenia research</jtitle><addtitle>Schizophr Res</addtitle><date>2012-07-01</date><risdate>2012</risdate><volume>138</volume><issue>2</issue><spage>192</spage><epage>197</epage><pages>192-197</pages><issn>0920-9964</issn><eissn>1573-2509</eissn><abstract>Abstract Background In selected samples, a considerable number of patients at clinical high risk of psychosis (CHR) are found to meet criteria for co-morbid clinical psychiatric disorders. It is not known how clinical diagnoses correspond to or even predict transitions to psychosis (TTP). Our aim was to examine distributions of life-time and current Axis I diagnoses, and their association with TTP in CHR patients. Methods In the EPOS (European Prediction of Psychosis Study) project, six European outpatient centres in four countries examined 245 young help-seeking patients, who fulfilled the inclusion criteria for clinical risk of psychosis according to the Structured Interview for Prodromal Syndromes (SIPS 3.0) or the Bonn Scale for the Assessment of Basic Symptoms — Prediction List basic symptoms (BASBS-P). Patients who had experienced a psychotic episode lasting more than one week were excluded. Baseline and life-time diagnoses were assessed by the Structured Clinical Interview for DSM-IV (SCID-I). TTP was defined by continuation of BLIPS for more than seven days and predicted in Cox-regression analysis. Results Altogether, 71% of the CHR patients had one or more life-time and 62% one or more current SCID-I diagnosis; about a half in each category received a diagnosis of life-time depressive and anxiety disorder. Currently, 34% suffered from depressive and 39% from anxiety disorder. Four percent received a current SCID diagnosis of bipolar, and 6.5% of somatoform disorder. During follow-up, 37 (15.1%) patients had developed full-blown psychosis. In bivariate analyses, current non-psychotic bipolar disorder associated significantly with TTP. In multivariate analyses, current bipolar disorder, somatoform and unipolar depressive disorders associated positively, and anxiety disorders negatively, with TTP. Conclusions Both life-time and current mood and anxiety disorders are highly prevalent among clinical help-seeking CHR patients and need to be carefully evaluated. Among CHR patients, occurrence of bipolar, somatoform and depressive disorders seems to predict TTP, while occurrence of anxiety disorder may predict non-transition to psychosis.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>22464922</pmid><doi>10.1016/j.schres.2012.03.008</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0920-9964 |
ispartof | Schizophrenia research, 2012-07, Vol.138 (2), p.192-197 |
issn | 0920-9964 1573-2509 |
language | eng |
recordid | cdi_proquest_miscellaneous_1031159496 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adolescent Adult Adult and adolescent clinical studies Anxiety Disorders - epidemiology Axis I diagnoses Biological and medical sciences Bipolar Disorder - epidemiology Clinical high-risk patients Comorbidity Depressive Disorder - epidemiology Europe - epidemiology Female Follow-Up Studies Humans Male Medical sciences Other psychotic disorders Prospective Studies Psychiatry Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychoses Psychotic Disorders - epidemiology Risk Factors Somatoform Disorders - epidemiology Transition to psychosis |
title | Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: Prospective follow-up of 245 clinical high-risk outpatients in four countries |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A51%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Axis%20I%20diagnoses%20and%20transition%20to%20psychosis%20in%20clinical%20high-risk%20patients%20EPOS%20project:%20Prospective%20follow-up%20of%20245%20clinical%20high-risk%20outpatients%20in%20four%20countries&rft.jtitle=Schizophrenia%20research&rft.au=Salokangas,%20Raimo%20K.R&rft.aucorp=the%20EPOS%20group&rft.date=2012-07-01&rft.volume=138&rft.issue=2&rft.spage=192&rft.epage=197&rft.pages=192-197&rft.issn=0920-9964&rft.eissn=1573-2509&rft_id=info:doi/10.1016/j.schres.2012.03.008&rft_dat=%3Cproquest_cross%3E1031159496%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1031159496&rft_id=info:pmid/22464922&rft_els_id=S0920996412001612&rfr_iscdi=true |